These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 30891102)
21. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer. Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250 [TBL] [Abstract][Full Text] [Related]
22. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer. Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956 [TBL] [Abstract][Full Text] [Related]
23. Total Blood Exosomes in Breast Cancer: Potential Role in Crucial Steps of Tumorigenesis. Konoshenko M; Sagaradze G; Orlova E; Shtam T; Proskura K; Kamyshinsky R; Yunusova N; Alexandrova A; Efimenko A; Tamkovich S Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33027894 [TBL] [Abstract][Full Text] [Related]
24. Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer. Su YY; Sun L; Guo ZR; Li JC; Bai TT; Cai XX; Li WH; Zhu YF J Ovarian Res; 2019 Jan; 12(1):6. PubMed ID: 30670062 [TBL] [Abstract][Full Text] [Related]
25. Docosahexaenoic acid (DHA) inhibits pro-angiogenic effects of breast cancer cells via down-regulating cellular and exosomal expression of angiogenic genes and microRNAs. Aslan C; Maralbashi S; Kahroba H; Asadi M; Soltani-Zangbar MS; Javadian M; Shanehbandi D; Baradaran B; Darabi M; Kazemi T Life Sci; 2020 Oct; 258():118094. PubMed ID: 32673663 [TBL] [Abstract][Full Text] [Related]
26. Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma. Tanaka Y; Kamohara H; Kinoshita K; Kurashige J; Ishimoto T; Iwatsuki M; Watanabe M; Baba H Cancer; 2013 Mar; 119(6):1159-67. PubMed ID: 23224754 [TBL] [Abstract][Full Text] [Related]
27. Exosomal miRNA Analysis in Non-small Cell Lung Cancer (NSCLC) Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool. Giallombardo M; Chacártegui Borrás J; Castiglia M; Van Der Steen N; Mertens I; Pauwels P; Peeters M; Rolfo C J Vis Exp; 2016 May; (111):. PubMed ID: 27285610 [TBL] [Abstract][Full Text] [Related]
28. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells. Yoshimura A; Sawada K; Nakamura K; Kinose Y; Nakatsuka E; Kobayashi M; Miyamoto M; Ishida K; Matsumoto Y; Kodama M; Hashimoto K; Mabuchi S; Kimura T BMC Cancer; 2018 Nov; 18(1):1065. PubMed ID: 30396333 [TBL] [Abstract][Full Text] [Related]
29. Morphological and molecular features of oral fluid-derived exosomes: oral cancer patients versus healthy individuals. Zlotogorski-Hurvitz A; Dayan D; Chaushu G; Salo T; Vered M J Cancer Res Clin Oncol; 2016 Jan; 142(1):101-10. PubMed ID: 26115960 [TBL] [Abstract][Full Text] [Related]
30. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer. Liu T; Zhang X; Gao S; Jing F; Yang Y; Du L; Zheng G; Li P; Li C; Wang C Oncotarget; 2016 Dec; 7(51):85551-85563. PubMed ID: 27888803 [TBL] [Abstract][Full Text] [Related]
31. Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer. Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H Oncotarget; 2016 Mar; 7(13):16923-35. PubMed ID: 26943577 [TBL] [Abstract][Full Text] [Related]
32. Human extracellular vesicles and correlation with two clinical forms of toxoplasmosis. da Cruz AB; Maia MM; Pereira IS; Taniwaki NN; Namiyama GM; Telles JPM; Vidal JE; Spegiorin LCJF; Brandão de Mattos CC; Mattos LC; Meira-Strejevitch CDS; Pereira-Chioccola VL PLoS One; 2020; 15(3):e0229602. PubMed ID: 32126572 [TBL] [Abstract][Full Text] [Related]
33. The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs. Bahrami A; Aledavood A; Anvari K; Hassanian SM; Maftouh M; Yaghobzade A; Salarzaee O; ShahidSales S; Avan A J Cell Physiol; 2018 Feb; 233(2):774-786. PubMed ID: 28109133 [TBL] [Abstract][Full Text] [Related]
34. Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma. Lee YR; Kim G; Tak WY; Jang SY; Kweon YO; Park JG; Lee HW; Han YS; Chun JM; Park SY; Hur K Int J Cancer; 2019 Mar; 144(6):1444-1452. PubMed ID: 30338850 [TBL] [Abstract][Full Text] [Related]
35. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling. Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916 [TBL] [Abstract][Full Text] [Related]
37. Serum exosomal miR-200c is a potential diagnostic biomarker for breast cancer. Qiao P; Du H; Guo X; Yu M; Zhang C; Shi Y Biomarkers; 2024 Oct; ():1-8. PubMed ID: 39317236 [TBL] [Abstract][Full Text] [Related]
38. Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients. Eichelser C; Stückrath I; Müller V; Milde-Langosch K; Wikman H; Pantel K; Schwarzenbach H Oncotarget; 2014 Oct; 5(20):9650-63. PubMed ID: 25333260 [TBL] [Abstract][Full Text] [Related]
39. miRNA profiling in vitreous humor, vitreal exosomes and serum from uveal melanoma patients: Pathological and diagnostic implications. Ragusa M; Barbagallo C; Statello L; Caltabiano R; Russo A; Puzzo L; Avitabile T; Longo A; Toro MD; Barbagallo D; Valadi H; Di Pietro C; Purrello M; Reibaldi M Cancer Biol Ther; 2015; 16(9):1387-96. PubMed ID: 25951497 [TBL] [Abstract][Full Text] [Related]
40. No Significant Difference between Plasma miRNAs and Plasma-Derived Exosomal miRNAs from Healthy People. Tian F; Shen Y; Chen Z; Li R; Ge Q Biomed Res Int; 2017; 2017():1304816. PubMed ID: 28656135 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]